Cargando…
New Ways to Treat Tuberculosis Using Dendrimers as Nanocarriers
Tuberculosis (TB) is a contagious infection that usually attacks not only the lungs, but also brain and spine. More than twenty drugs have been developed for the treatment of TB, but most of them were developed some years ago. They are used in different combinations. Isoniazid and Rifampicin are exa...
Autores principales: | Mignani, Serge, Tripathi, Rama Pati, Chen, Liang, Caminade, Anne-Marie, Shi, Xiangyang, Majoral, Jean-Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161254/ https://www.ncbi.nlm.nih.gov/pubmed/30049938 http://dx.doi.org/10.3390/pharmaceutics10030105 |
Ejemplares similares
-
Which Dendrimer to Attain the Desired Properties? Focus on Phosphorhydrazone Dendrimers†
por: Caminade, Anne-Marie, et al.
Publicado: (2018) -
Doxorubicin-Conjugated PAMAM Dendrimers for pH-Responsive Drug Release and Folic Acid-Targeted Cancer Therapy
por: Zhang, Mengen, et al.
Publicado: (2018) -
Bifunctional Phosphorus Dendrimers and Their Properties
por: Caminade, Anne-Marie, et al.
Publicado: (2016) -
Non-invasive intranasal administration route directly to the brain using dendrimer nanoplatforms: An opportunity to develop new CNS drugs
por: Mignani, Serge, et al.
Publicado: (2021) -
Enhanced Delivery of Therapeutic siRNA into Glioblastoma Cells Using Dendrimer-Entrapped Gold Nanoparticles Conjugated with β-Cyclodextrin
por: Qiu, Jieru, et al.
Publicado: (2018)